Cencora (COR)Director bought ~$1.07M

~$1.07M

Approx. value · 4,000 sh @ $266.26

28K

Holds after · shares reported

Traded

May 28, 2026

Filed

May 29, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Feb 2, 2026Federal contract · $4.3M obligatedDepartment of Defense awarded Cencora: $4.34M obligated to date
2. Feb 3, 2026Federal contract · $4.9M obligatedDepartment of Defense awarded Cencora: $4.93M obligated to date
3. Feb 18, 2026Federal contract · $5.2M obligatedDepartment of Defense awarded Cencora: $5.18M obligated to date
4. Feb 18, 2026Federal contract · $4.8M obligatedDepartment of Defense awarded Cencora: $4.79M obligated to date
5. Mar 11, 2026Federal contract · $9.0M obligatedDepartment of Defense awarded Cencora: $9.01M obligated to date
6. Mar 23, 2026Congress · 1 personMembers of Congress: 2 purchases
7. Mar 27, 2026CongressDisclosed purchase of COR — reported range $1,001 - $15,000
8. Mar 31, 2026CongressDisclosed purchase of COR — reported range $1,001 - $15,000
9. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.3%
10. May 1, 2026FDARecall: Primidone Tablets, USP, 50 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Ca…
11. May 1, 2026FDARecall: Primidone Tablets, USP, 250 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. C…
12. May 6, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
13. May 6, 2026Congress · 1 personMembers of Congress: 2 sales
14. May 13, 2026Federal contract · $4.5M obligatedDepartment of Defense awarded Cencora: $4.5M obligated to date
15. May 13, 2026Federal contract · $4.3M obligatedDepartment of Defense awarded Cencora: $4.25M obligated to date
16. May 23, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On May 27, 2026, Cencora, Inc. (the “Company”) announced that Eva C. Boratto has been appointed Executive Vice President and Chief Financial Officer of the Company (the “Appointment”), effective June 29, 2026 (the “Effective Date”).”
17. May 28, 2026 · this disclosureInsider · Largest insider buy since 2006Director purchased ~$1.07M of COR shares in the open market

What came next

1. May 28, 2026Federal contract · $4.2M obligatedDepartment of Defense awarded Cencora: $4.24M obligated to date
2. Jun 10, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On June 15, 2026, Cencora, Inc. (the “Company”) announced that Silvana Battaglia will retire as Executive Vice President and Chief Human Resources Officer of the Company effective July 12, 2026.”
3. Jun 12, 2026Federal contract · $7.7M obligatedDepartment of Defense awarded Cencora: $7.74M obligated to date
4. Jun 18, 2026InsiderDirector purchased ~$1.1M of COR shares in the open market
5. Jun 22, 2026Insider · Their first buy on recordDirector purchased ~$149K of COR shares in the open market
6. Jul 31, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
7. Aug 5, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
8. Aug 13, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 13, 2026, following the conclusion of the quarterly meeting of the Board of Directors (the “Board”) of Cencora, Inc. (the “Company”), Lorence H. Kim, M.D., informed the Company of his intent to resign from the Board effective immediately.”
9. Aug 20, 2026Federal contract · $39K obligatedDepartment of Veterans Affairs awarded Cencora: $39K obligated to date
10. Aug 24, 2026Insider · Their largest sale since 2022Officer sold ~$3.66M of COR shares in the open market
11. Sep 1, 2026InsiderOfficer sold ~$321K of COR shares in the open market
12. Sep 16, 2026InsiderDirector sold ~$411K of COR shares in the open market
13. Sep 24, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 24, 2026, the Board of Directors (the “Board”) of Cencora, Inc. (the “Company”) appointed Robert E. Sanchez to serve on the Board (the “Appointment”), effective October 1, 2026 (the “Effective Date”).”

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cencora

For Cencora, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 1 Congress trade report, 29 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its COR page.

Other recent filings by Dermot Mark Durcan, Director

• SEC Form 4 at Cencora (COR)Jun 23, 2026

The full history of Dermot Mark Durcan, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Cencora

• SEC Form 4Oct 5, 2026
• SEC Form 4Sep 17, 2026
• SEC Form 144Sep 16, 2026
• SEC Form 144Sep 11, 2026
• SEC Form 144Sep 4, 2026
• SEC Form 4Sep 3, 2026

Everything OQRO holds on this company is on its COR page.